• Produktbild: Law and the Regulation of Medicines
  • Produktbild: Law and the Regulation of Medicines

Law and the Regulation of Medicines

79,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.03.2012

Verlag

Bloomsbury Academic

Seitenzahl

320

Maße (L/B/H)

23,4/15,6/1,8 cm

Gewicht

488 g

Sprache

Englisch

ISBN

978-1-84946-179-5

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.03.2012

Verlag

Bloomsbury Academic

Seitenzahl

320

Maße (L/B/H)

23,4/15,6/1,8 cm

Gewicht

488 g

Sprache

Englisch

ISBN

978-1-84946-179-5

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Law and the Regulation of Medicines
  • Produktbild: Law and the Regulation of Medicines
  • 1 What are Medicines and why are they Special?
    I Why Medicines are Special
    II The Development of a Special Regulatory Regime for Medicines
    III What is a Medicine?
    IV Complementary and Alternative Medicines
    V Conclusion
    2 Clinical Trials
    I What are Clinical Trials?
    II Regulating Trials
    III Ethical Review
    IV Trials and Industry
    V The Global Trials Industry
    VI Conclusion
    3 Licensing
    I The Significance of a Marketing Authorisation
    II Applying for a Marketing Authorisation
    III Grounds for Licensing Decisions
    IV Relationship between Regulators and Industry
    V Classification of Medicines
    VI Buying Prescription Drugs Online
    VII Conclusion
    4 Pharmacovigilance and Liability for Dangerous Drugs
    I Post-marketing Surveillance
    II The Consequences of Identifying Drug Safety Hazards
    III Liability for Drug Injuries
    IV Conclusion
    5 Marketing
    I Direct to Consumer Advertising
    II Selling Diseases
    III Patient Groups
    IV Public Relations
    V The Relationship between Doctors and the Pharmaceutical Industry
    VI Conclusion
    6 Funding and Access to Medicines in the UK
    I The Costs of Prescription Medicines
    II The Pharmaceutical Price Regulation Scheme
    III Value-Based Pricing
    IV The National Institute for health and Clinical Excellence (NICE)
    V Exceptional Case Review
    VI Judicial Review
    VII Top-Up Payments
    VIII Conclusion
    7 Funding and Access to Medicines: A Global Problem
    I The Problem of Unaffordable Medicines
    II TRIPs, Doha and Generics
    III Incentives to Develop and Supply Treatments in Low-income Countries
    IV Humanitarian, Charitable and Philanthropic Initiatives
    VI Conclusion
    8 The Future of Medicines I: Pharmacogenetics
    I The Limitations of Genetic Testing
    II An Expansion in Genetic Testing: Consent and Confidentiality
    III Resource Implications
    IV Cost-effectiveness and Orphan Patients
    V Clinical Trials
    VI Licensing
    VII Withdrawn Medicines?
    VIII Improved Post-licensing Surveillance?
    IX Liability for Harm
    X Conclusion
    9 The Future of Medicines II: Enhancement
    I The Line between Treatment and Enhancement
    II A Pharmacological Fix?
    III Enhancing Sporting Ability and Cheating
    IV A Parallel with Education?
    V Distributional Justice
    VI Coercion
    VII Prescription Drug Abuse
    VIII Transhumanism and Posthumanism: Utopia or the End of History?
    IX Conclusion
    Concluding Remarks